Effect of enforced physical inactivity induced by 60-day of bed rest on hepatic markers of NAFLD in healthy normal-weight women

Liver International

Volumn 35, Issue 6, 2015, Pages 1700-1706

  Rudwill, Floriane ^a,b   Bergouignan, Audrey ^c   Gastebois, Caroline ^d   Gauquelin Koch, Guillemette ^e   Lefai, Etienne ^d   Blanc, Stéphane ^a,b   Simon, Chantal ^d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CNRS   (France)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITÉ LYON 1   (France)

^e CNES   (France)

Author keywords

Angiopoietin like 3; Cytokeratin 18; Exercise; Physical inactivity; Steatohepatitis; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOPOIETIN; ANGIOPOIETIN LIKE 3 PROTEIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKERATIN 18; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANGPTL3 PROTEIN, HUMAN;

ADULT; AEROBIC EXERCISE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BED REST; BODY COMPOSITION; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIVER METABOLISM; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; NORMAL HUMAN; PHYSICAL INACTIVITY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BODY MASS; ENERGY METABOLISM; INSULIN RESISTANCE; LIVER; METABOLISM; PHYSIOLOGY;

ADULT; ALANINE TRANSAMINASE; ANGIOPOIETINS; ASPARTATE AMINOTRANSFERASES; BED REST; BIOMARKERS; BODY COMPOSITION; BODY MASS INDEX; ENERGY METABOLISM; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INSULIN; INSULIN RESISTANCE; KERATIN-18; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84929129442     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12743     Document Type: Article

References (40)

1. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-5.
2. Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24: 695-708.
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43(2 Suppl. 1): 99-112.
4. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6: 274-83.
5. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
6. Laaksonen DE, Lakka HM, Salonen JT, et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002; 25: 1612-8.
7. Healy GN, Dunstan DW, Salmon J, et al. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 2008; 31: 661-6.
8. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatology 2008; 48: 1791-8.
9. Perseghin G, Lattuada G, De Cobelli F, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 2007; 30: 683-8.
10. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y. Regular physical activity and coronary risk factors in Japanese men. Circulation 1998; 97: 661-5.
11. George AS, Bauman A, Johnston A, Farrell G. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009; 50: 68-76.
12. Anty R, Iannelli A, Patouraux S, et al. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Ther 2010; 32: 1315-22.
13. Yilmaz Y, Kedrah AE, Ozdogan O. Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis. World J Gastroenterol 2009; 15: 4387-91.
14. Li C. A tale of two angiopoietin-like proteins. Curr Opin Lipidol 2007; 18: 597-9.
15. Yilmaz Y, Ulukaya E, Atug O, Dolar E. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. Eur J Gastroenterol Hepatol 2009; 21: 1247-51.
16. Bergouignan A, Momken I, Schoeller DA, et al. Regulation of energy balance during long-term physical inactivity induced by bed rest with and without exercise training. J Clin Endocrinol Metab 2010; 95: 1045-53.
17. Bergouignan A, Trudel G, Simon C, et al. Physical inactivity differentially alters dietary oleate and palmitate trafficking. Diabetes 2009; 58: 367-76.
18. Polyzos SA, Kountouras J, Papatheodorou A, et al. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: introduction of CHA index. Ann Hepatol 2013; 12: 749-57.
19. Rector RS, Thyfault JP. Does physical inactivity cause nonalcoholic fatty liver disease? J Appl Physiol 2011; 111: 1828-35.
20. Rector RS, Thyfault JP, Laye MJ. Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J Physiol 2008; 586: 4241-9.
21. Zderic TW, Hamilton MT. Physical inactivity amplifies the sensitivity of skeletal muscle to the lipid-induced downregulation of lipoprotein lipase activity. J Appl Physiol 2006; 100: 249-57.
22. Burgert TS, Taksali SE, Dziura J, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-94.
23. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008; 115: 141-50.
24. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57: 1441-7.
25. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-23.
26. Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50: 1072-8.
27. Trudel G, Payne M, Madler B, et al. Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study. J Appl Physiol 2009; 107: 540-8.
28. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7.
29. Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies. J Appl Physiol 2011; 111: 1201-10.
30. Hickman IJ, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413-9.
31. Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50: 1105-12.
32. Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 57: 157-66.
33. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011; 60: 1278-83.
34. van der Heijden GJ, Wang ZJ, Chu ZD, et al. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese Hispanic adolescents. Obesity 2010; 18: 384-90.
35. Fealy CE, Haus JM, Solomon TP, et al. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol 2012; 113: 1-6.
36. Beck EB, Erbs S, Mobius-Winkler S, et al. Exercise training restores the endothelial response to vascular growth factors in patients with stable coronary artery disease. Eur J Prev Cardiol 2012; 19: 412-8.
37. Beaton MD. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Can J Gastroenterol 2012; 26: 353.
38. Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44: 27-33.
39. Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006; 6: 6.
40. Biolo G, Agostini F, Simunic B, et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 2008; 88: 950-8.